Skip to Content
Merck
  • Comparative study on the response of rat primary astrocytes and microglia to methylmercury toxicity.

Comparative study on the response of rat primary astrocytes and microglia to methylmercury toxicity.

Glia (2011-02-26)
Mingwei Ni, Xin Li, Zhaobao Yin, Marta Sidoryk-Węgrzynowicz, Haiyan Jiang, Marcelo Farina, Joao B T Rocha, Tore Syversen, Michael Aschner
ABSTRACT

As the two major glial cell types in the brain, astrocytes and microglia play pivotal but different roles in maintaining optimal brain function. Although both cell types have been implicated as major targets of methylmercury (MeHg), their sensitivities and adaptive responses to this metal can vary given their distinctive properties and physiological functions. This study was carried out to compare the responses of astrocytes and microglia following MeHg treatment, specifically addressing the effects of MeHg on cell viability, reactive oxygen species (ROS) generation and glutathione (GSH) levels, as well as mercury (Hg) uptake and the expression of NF-E2-related factor 2 (Nrf2). Results showed that microglia are more sensitive to MeHg than astrocytes, a finding that is consistent with their higher Hg uptake and lower basal GSH levels. Microglia also demonstrated higher ROS generation compared with astrocytes. Nrf2 and its downstream genes were upregulated in both cell types, but with different kinetics (much faster in microglia). In summary, microglia and astrocytes each exhibit a distinct sensitivity to MeHg, resulting in their differential temporal adaptive responses. These unique sensitivities appear to be dependent on the cellular thiol status of the particular cell type.

MATERIALS
Product Number
Brand
Product Description

Roche
cOmplete Protease Inhibitor Cocktail, Tablets provided in EASYpacks